Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Aethlon Medical, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 2 | -$0.14 | -$0.13 | -$0.14 |
Aethlon Medical, Inc. Earnings Date And Information
Aethlon Medical, Inc. last posted its earnings results on Wednesday, February 12th, 2025. The company reported $-0.13 earnings per share for the quarter, topping analysts' consensus estimates of $-0.22 by $0.09. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Aethlon Medical, Inc. has generated $-5 earnings per share over the last year ($-4.86 diluted earnings per share) and currently has a price-to-earnings ratio of -0.51. Aethlon Medical, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 25th, 2025 based on prior year's report dates.
Aethlon Medical, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 02/12/2025 | Q3 2025 | -$0.22 | -$0.13 | 0.09 | $0 | $0 |
| 11/13/2024 | Q2 2025 | -$0.20 | -$0.20 | 0 | $0 | $0 |
| 08/14/2024 | Q1 2025 | -$0.44 | -$0.34 | 0.1 | $0 | $0 |
| 08/15/2024 | Q4 2024 | N/A | -$0.92 | N/A | N/A | $0 |
| 02/14/2024 | Q3 2024 | -$1.23 | -$1.38 | -0.15 | N/A | $0 |
| 11/14/2023 | Q2 2024 | -$1.35 | -$1.22 | 0.13 | N/A | $0 |
| 08/10/2023 | Q1 2024 | -$1.20 | -$1.40 | -0.2 | N/A | $0 |
| 06/28/2023 | Q4 2023 | -$1.60 | -$1.11 | 0.49 | N/A | $574,245 |
| 02/13/2023 | Q3 2023 | -$0.40 | -$1.24 | -0.84 | $4.76 M | $0 |
| 11/14/2022 | Q2 2023 | -$2.30 | -$1.84 | 0.46 | $69,550 | $0 |
| 08/09/2022 | Q1 2023 | -$2.40 | -$1.90 | 0.5 | $69,300 | $0 |
| 06/28/2022 | Q4 2022 | -$1.20 | -$2.46 | -1.26 | $720,867 | $13,116 |
| 02/14/2022 | Q3 2022 | -$1.30 | -$1.64 | -0.34 | $212,400 | $17,117 |
| 11/09/2021 | Q2 2022 | -$1.50 | -$1.31 | 0.19 | $208,500 | $131,966 |
| 08/09/2021 | Q1 2022 | -$1.30 | -$1.63 | -0.33 | $175,000 | $131,966 |
| 06/24/2021 | Q4 2021 | -$2.00 | -$1.55 | 0.45 | $373,367 | $34,233 |
| 02/10/2021 | Q3 2021 | -$1.50 | -$2.02 | -0.52 | $100,000 | $624,871 |
| 10/28/2020 | Q2 2021 | -$1.20 | -$1.47 | -0.27 | N/A | $0 |
| 08/11/2020 | Q1 2021 | N/A | -$1.46 | N/A | N/A | $0 |
| 06/25/2020 | Q4 2020 | -$0.16 | -$2.18 | -2.02 | $287,500 | $206,729 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Aethlon Medical, Inc. Earnings: FAQ's
Aethlon Medical, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, June 25th, 2025 based offlast year's report dates.
In the previous quarter, Aethlon Medical, Inc. (:AEMD) reported $-0.13 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.22 by $0.09.
The conference call for Aethlon Medical, Inc.'s latest earnings report can be listened to online.
The conference call transcript for Aethlon Medical, Inc.'s latest earnings report can be read online.
Aethlon Medical, Inc. (:AEMD) has a recorded net income of $-12,208,174.Aethlon Medical, Inc. has generated $-4.86 earnings per share over the last four quarters.
Aethlon Medical, Inc. (:AEMD) has a price-to-earnings ratio of -0.51 and price/earnings-to-growth ratio is -0.01.